Clinical Trial Categories
Myeloma Trials
USOR 20285
Avavilable at 13 locations
A Phase II Trial of Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Combination with Selinexor for Patients with Newly Diagnosed Multiple Myeloma